Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1062006

COc1c(C(=O)NCCN2CCCCC2)sc2c1c(=O)n(Cc1ccccn1)c1ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.43
▸ LMNA P02545 4/20 0.43
▸ PARP1 P09874 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TSHR P16473 4/20 0.39
▸ PKM P14618 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 5/20 0.38
▸ HTT P42858 3/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ USP2 O75604 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ BTK Q06187 1/20 0.38
▸ CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10314332 0.95 KDM4E (0.46) KDM4ELMNAPARP1ALDH1A1HPGD
SCHEMBL10314324 0.94 PARP1 (0.45) KDM4ELMNAPARP1ALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL1080707 0.90 MAPT (0.45) KDM4EPARP1ALDH1A1HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL1062144 0.89 KDM4E (0.45) KDM4EPARP1ALDH1A1HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL1062441 0.89 KMT2A (0.46) KDM4ELMNAALDH1A1MAPK1TSHR
Trifluoroacetic Acid SCHEMBL1061583 0.88 ALDH1A1 (0.48) KDM4ELMNAALDH1A1HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL1062062 0.88 CACNA1B (0.42) KDM4ELMNAALDH1A1TSHRPKM
Trifluoroacetic Acid SCHEMBL1063790 0.87 RAB9A (0.44) KDM4ELMNAALDH1A1HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL1061358 0.87 ALDH1A1 (0.39) KDM4ELMNAALDH1A1MAPK1TSHR
Trifluoroacetic Acid SCHEMBL1061796 0.87 KDM4E (0.49) KDM4ELMNAPARP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247588-B1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2016-04-13 — — EP disclosed
US-8399449-B2 Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-03-19 — — US disclosed
US-8217176-B2 Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-07-10 — — US disclosed
US-20110003788-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-06 — — US disclosed
US-20090227561-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003788-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF SMO, NR1H2, NR1H4 KDM4E 528/4885LMNA 4534/4885PARP1 4130/4885
US-20090227561-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF SMO, NR1H2, NR1H4 KDM4E 464/4885LMNA 4392/4885PARP1 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback